UniversityListed in 1 ranking
Nijmegen’s municipal economic vision presents the city as a health and high-tech center, naming semiconductor activity, digital health, medicine development, and brain research as local strengths.
Nijmegen’s municipal economic vision presents the city as a health and high-tech center, naming semiconductor activity, digital health, medicine development, and brain research as local strengths.
The Launch describes itself as an early-stage pre-incubator at Heyendaal Campus. It lists workshops and events, business coaching, lab and office access, funding guidance, and network connections. The Launch says it began in 2018 for Heyendaal employees, PhD students, and students.
Radboud Science Park resident companies need a demonstrable connection to research at Radboud University or Radboudumc, according to the university.
Radboudumc’s spin-off directory lists Aiosyn and describes its pathology focus. Aiosyn identifies its research origin as Radboudumc’s Computational Pathology Group in Nijmegen. The company announced a €2 million funding round on December 21, 2022, led by Health Innovations with Oost NL and LUMO Labs. NXP’s corporate timeline records Philips semiconductor manufacturing and development in Nijmegen from 1953.
Startup ecosystem standing
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| 2025 | #280 | No prior edition | B | Ecosystem, Activity, Finance, Business Climate |
Pick what describes you
Investors based here, and the programs that take teams at your stage.
Get investor introsAccelerators and incubators here see the earliest teams first.
Get startups that fitCampuses and communities are where teams form before anyone funds them.
Start scoutingFrom public sources
NXP’s timeline records Philips semiconductor manufacturing and development in Nijmegen from 1953.
Source: NXP History: A TimelineAiosyn identifies its origin as Radboudumc’s Computational Pathology Group in Nijmegen.
Source: Aiosyn raises EUR 2 million to develop AI-powered algorithms to support pathologists with clinical diagnosticsAiosyn announced a €2 million round in December 2022, led by Health Innovations with Oost NL and LUMO Labs.
Source: Aiosyn raises EUR 2 million to develop AI-powered algorithms to support pathologists with clinical diagnosticsRadboudumc’s spin-off directory lists Aiosyn and describes its pathology focus.
Source: Spin-off companiesThe Launch says it began in 2018 for Heyendaal employees, PhD students, and students.
Source: About usThe Launch lists workshops, coaches, workspace, funding guidance, and network connections.
Source: About usIts best position is #280 in StartupBlink Index (cities) (2025).
One university has a profile: Radboud University.
Superscout Pro
Is this page right?How the research works